How Startup Cellcolabs Could Revolutionize Stem Cell Production
To date, the majority of stem cells have been obtained from adult stem cells or fetal tissue following termination. But...
Read moreDetailsTo date, the majority of stem cells have been obtained from adult stem cells or fetal tissue following termination. But...
Read moreDetailsGone are the days of manual labour and repetitive tasks. Nowadays, automated robots are seamlessly taking over these responsibilities, leaving...
Read moreDetailsFollowing a slight rise in 2023, methane emissions from fossil fuels are on the cusp of a significant decline, reveals...
Read moreDetailsThe UN Environment Programme’s (UNEP) International Resource Panel (IRP) has published the second edition of its Global Resources Outlook. The...
Read moreDetailsWealthy investors and asset managers wield a lot of power over the major companies whose stock they own or control. Every year,...
Read moreDetails
Impakter informs you through the ESG news site and empowers your business CSRD compliance and ESG compliance with its Klimado SaaS ESG assessment tool marketplace that can be found on: www.klimado.com
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2026 IMPAKTER. All rights reserved.